Stock screener

ENOV

Conviction 0HealthcareScan · Thu, Jun 25, 2026
ENOV$22.04+3.09%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 1.1M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Enovis CORPORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESwww.enovis.com
Price22.04
Change+3.09%
Gap+1.40%
Rel volume0.95×
Avg volume1.09M
Avg $ vol24.03M
SMA 2022.07
SMA 5023.66
SMA 20026.17
Price vs 50-6.84%
Price vs 200-15.77%
MA stackbearish
50/200 cross
Supertrenddown · 25.03
RSI (14)47
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D37 / 24
ADX (14)17
+DI / −DI20 / 22
RSI divergenceBullish
MACD divergenceBullish
ATR %+5.55%
ADR %5.09%
52w high35.94
52w low20.85
From 52w high-38.68%
Above 52w low+5.71%
New 52w highNo
SqueezeOff
Bollinger width16.84%
%B0.49
Donchian pos36.97%
Donchian high24.58
Donchian low20.55
AVWAP (52w high)26.58
vs AVWAP high-17.09%
AVWAP (52w low)21.49
vs AVWAP low+2.57%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d0.95×
Avg vol (14d)1.1M
Avg vol (20d)1.09M
Avg $ vol (20d)24.03M
Market cap1.27B
RS 3m (vs SPY)-15.56%
RS 6m (vs SPY)-27.84%
RS line new highNo
Trend template0/8
Technical rank25.3
1 week+5.71%
1 month-9.23%
3 months-2.56%
6 months-18.97%
1 year-31.04%
YTD-16.86%
P/E-1.07
P/B0.86
P/S0.56
P/FCF63.70
EPS-20.75
Div yield
ROE-80.20%
ROA-30.91%
Debt/Eq0.90
Current2.04
EV/EBITDA11.65
Gross margin59.84%
Net margin-52.69%
Rev growth6.66%
EPS growth-43.48%
Price target42.33
Target upside92.06%
Analyst ratingBuy
Institutional128.17%
Ent. value2.56B
Revenue589.15M
Net income-8.76M
Gross profit365.49M
Free cash flow19.92M
IndustryORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
ExchangeNYSE
Shares out57.56M
Employees7.8K
ListedThu, May 8, 2008
Free float55.64M
Float %97.1%
Short interest8.65M
Days to cover8.0d
Short volume47.7%
Squeeze score61 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast$0.83 · 2 est
Last EPS vs est$0.89 vs $0.82
Last surprise+8.5% beat
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank25.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance27.28
Support20.58
Days since event
Candle confirm
News sentiment

Financials as of Fri, Apr 3, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENOV

All disclosures →
No recent disclosed trades by Congress in ENOV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENOV · 9 buys

InsiderSideShares
Engert Oliver
Chief Administrative Officer · Common stock, par value $0.001 · 2026-06-01
Buy1K
PERFALL A CLAYTON
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Ortiz Christine
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Wienbar Sharon L
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Kelly Liam
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Lalor Angela S
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Shirley Brady
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
PERFALL A CLAYTON
Director · Common stock, par value $0.001 · 2026-05-19
Other
Vinnakota Rajiv
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K
Bodem Barbara W.
Director · Common stock, par value $0.001 · 2026-05-19
Grant9.35K

SEC filings

EDGAR filings in ENOV

EDGAR →

No recent SEC filings on file for ENOV.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.